Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Multiple sclerosis, an unlikely cause of chronic cerebrospinal venous insufficiency: retrospective analysis of catheter venography.
Observer bias in randomized clinical trials with time-to-event outcomes: systematic review of trials with both blinded and non-blinded outcome assessors.
Another promising oral agent for multiple sclerosis.
Adapted exercise interventions for persons with progressive multiple sclerosis.
Autocrine MMP-2/9 secretion increases the BBB permeability in neuromyelitis optica.
Individualized rituximab treatment for relapsing neuromyelitis optica: a pediatric case report.
Prevalence of Sexual Dysfunctions Among Women with Multiple Sclerosis.
Quality of life and patient preferences: identification of subgroups of multiple sclerosis patients.
Squinting Through Layers of Fog: Assessing the Cost Effectiveness of Treatments for Multiple Sclerosis.
Quantifying progression of multiple sclerosis via classification of depth videos.
Health-related quality of life in relapsing remitting multiple sclerosis patients during treatment with glatiramer acetate: a prospective, observational, international, multi-centre study.
Ultra-High-Field MRI Visualization of Cortical Multiple Sclerosis Lesions with T2 and T2*: A Postmortem MRI and Histopathology Study.
Leber hereditary optic neuropathy and multiple sclerosis: the mitochondrial connection.
Obstructive sleep apnea is associated with fatigue in multiple sclerosis.
Differentiating patterns of oligoclonal banding in the cerebrospinal fluid and the diagnosis of multiple sclerosis.
Block of a subset of sodium channels exacerbates experimental autoimmune encephalomyelitis.
Zinc sulphate: A reasonable choice for depression management in patients with multiple sclerosis: A randomized, double-blind, placebo-controlled clinical trial.
Somatosensory temporal discrimination threshold is impaired in patients with multiple sclerosis.
Spatial reference memory deficits precede motor dysfunction in an experimental autoimmune encephalomyelitis model: The role of kallikrein-kinin system.
Neurofascin antibodies in inflammatory neuropathy: How many needles make a haystack?
T cell responses after hematopoietic stem cell transplantation for aggressive relapsing-remitting multiple sclerosis.
JC virus detection and JC virus-specific immunity in natalizumab-treated Multiple Sclerosis patients.
Articulation time does not affect speeded cognitive performance in multiple sclerosis.
Comment on 'Fingolimod to treat severe MS after natalizumab-associated progressive multifocal leukoencephalopathy: a valid option?' Maillart et al.
Step-rate thresholds for physical activity intensity in persons with multiple sclerosis.
Pages
« first
‹ previous
…
381
382
383
384
385
386
387
388
389
…
next ›
last »